Translational Development Acquisition CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Translational Development Acquisition Corp. is asking shareholders to approve a 12-month extension to complete its business combination with ProLogium.